会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • Method of producing hydrogen-storing alloy and electrode making use of
the alloy
    • 使用该合金制备储氢合金和电极的方法
    • US5281390A
    • 1994-01-25
    • US870224
    • 1992-04-20
    • Takaharu GamoYoshio MoriwakiTsutomu IwakiAkemi Shintani
    • Takaharu GamoYoshio MoriwakiTsutomu IwakiAkemi Shintani
    • C01B3/00C22C1/02H01M4/38C22C16/00C22C30/00
    • C01B3/0031C22C1/02H01M4/383Y02E60/327Y10S420/90
    • In the method of the present invention for producing a hydrogen-storing alloy, part or whole of single substance of Zr as a starting material is replaced with a ferrozirconium or a zircalloy. This method enables production of a hydrogen-storing alloy at reduced material and production costs and with high efficiency and safety of work. The alloy produced by this method has high homogeneity with no segregation. It is thus possible to obtain a hydrogen-storing alloy superior in hydrogen-storing characteristics such as hydrogen storage capacity, reaction speed, and electrode reaction efficiency in an electrolyte. It is also possible to obtain, by using this alloy, a nickel-hydrogen storage battery having a large storage capacity and capable of performing quick charging and discharging, while exhibiting longer life and higher economy.
    • PCT No.PCT / JP89 / 01319 Sec。 371日期1990年8月2日第 102(e)1990年8月2日PCT PCT 1989年12月28日PCT公布。 公开号WO90 / 07585 日本1990年7月12日。在本发明的制备储氢合金的方法中,作为起始原料的Zr的单一物质的一部分或全部被铁氟化锆或锆合金代替。 该方法能够以减少的材料和生产成本以及高效率和安全的工作生产储氢合金。 通过该方法制造的合金具有高均匀性,没有偏析。 因此,可以获得在电解液中的储氢能力,反应速度,电极反应效率等储氢特性优异的储氢合金。 通过使用这种合金,也可以获得具有大存储容量并能够进行快速充放电的镍氢蓄电池,同时具有更长的寿命和更高的经济性。
    • 14. 发明授权
    • Glycopeptide antibiotic derivative
    • 糖肽抗生素衍生物
    • US08933012B2
    • 2015-01-13
    • US12224443
    • 2007-05-25
    • Yasuhiro NishitaniOsamu YoshidaTsutomu IwakiIssei Kato
    • Yasuhiro NishitaniOsamu YoshidaTsutomu IwakiIssei Kato
    • A61K38/00A61P31/04A01N43/40A61K31/445C07K9/00A61K38/04
    • C07K9/008A61K38/00A61K38/04
    • The present invention provides a novel glycopeptide antibiotic derivative.These derivatives are represented by the formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein RA is —X1—Ar1—X2—Y—X3—Ar2 wherein X1, X2 and X3 are single bond; heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR1— (R1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO2—, or a linkage thereof; or alkylene or alkenylene optionally substituted and optionally interrupted by one or more of said heteroatom-containing group; Y is —NR2CO—, —CONR2— (R2 is hydrogen or lower alkyl), or a group of the formula (II) wherein R3 is alkylene; Ar1 and Ar2 are a carbocycle or a heterocycle which is optionally substituted and may have an unsaturated bond; RB is —NHNRXRY or —NRZORW wherein RX is hydrogen or lower alkyl; RY is hydrogen, optionally substituted lower alkyl, C(═NH)NH2, CSNH2, COCONH2, CN, optionally substituted heterocyclic group, and optionally substituted carbamoyl; RZ is hydrogen or lower alkyl; RW is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted heterocyclic group, optionally substituted heterocyclic carbonyl or optionally substituted carbamoyl; RC is hydrogen or optionally substituted alkyl, wherein said alkyl may be interrupted by a heteroatom-containing group selected from N═, ═N—, —NR1— (R1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO2—; and R is optionally substituted alkyl.
    • 本发明提供了一种新型糖肽抗生素衍生物。 这些衍生物由式(I)表示或其药学上可接受的盐或溶剂化物,其中RA为-X1-Ar1-X2-Y-X3-Ar2,其中X1,X2和X3为单键; 选自-N =,N-,-NR1-(R 1为氢或低级烷基), - O - , - S - , - SO-和-SO 2 - 的杂原子的基团,或其连接基 ; 或任选被取代并任选被一个或多个所述含杂原子基团中断的亚烷基或亚烯基; Y是-NR 2 CO-,-CONR 2 - (R 2是氢或低级烷基)或式(II)的基团,其中R 3是亚烷基; Ar1和Ar2是任选被取代并可具有不饱和键的碳环或杂环; RB是-NHNRXRY或-NRZORW,其中RX是氢或低级烷基; RY是氢,任选取代的低级烷基,C(= NH)NH 2,CSNH 2,COCONH 2,CN,任选取代的杂环基和任选取代的氨基甲酰基; RZ是氢或低级烷基; RW是氢,任选取代的低级烷基,任选取代的低级烯基,任选取代的杂环基,任选取代的杂环羰基或任选取代的氨基甲酰基; RC是氢或任选取代的烷基,其中所述烷基可以被选自N =,N-,-NR1-(R 1是氢或低级烷基),-O - , - S - , - SO-和-SO 2 - ; R是任选取代的烷基。
    • 15. 发明授权
    • Information processing apparatus and display control method
    • 信息处理装置及显示控制方法
    • US08294725B2
    • 2012-10-23
    • US12777119
    • 2010-05-10
    • Tsutomu IwakiKoji Hachiya
    • Tsutomu IwakiKoji Hachiya
    • G09G5/36
    • G09G5/363G09G3/003G09G5/14G09G5/393G09G2300/026G09G2330/021G09G2360/122G09G2370/027
    • According to one embodiment, an information processing apparatus comprises video memories each corresponding to each of the display devices, a determination module configured to determine whether an access that satisfies conditions preset with respect to display of the display devices exists in at least one of the video memories, and a changing module configured to change, when the determination module determines that the access that satisfies conditions preset with respect to display of the display devices does not exist in at least one of the video memories, an operation state of a display device corresponding to the at least one of the video memories determined that an access does not exist, from a first operation state to a second operation state having a power consumption lower than a power consumption of the first operation state.
    • 根据一个实施例,信息处理设备包括每个对应于每个显示设备的视频存储器,确定模块被配置为确定满足关于显示设备的显示的预设条件的访问是否存在于视频的至少一个中 存储器和改变模块,其被配置为当所述确定模块确定满足关于所述显示设备的显示预设的条件的访问不存在于所述视频存储器的至少一个中时,改变对应于所述显示设备的操作状态 将确定存在不存在的视频存储器中的至少一个从第一操作状态转换为具有低于第一操作状态的功耗的功耗的第二操作状态。
    • 18. 发明申请
    • Glycopeptide Antibiotic Derivative
    • 糖肽抗生素衍生物
    • US20090286717A1
    • 2009-11-19
    • US12224443
    • 2007-05-25
    • Yasuhiro NishitaniOsamu YoshidaTsutomu IwakiIssei Kato
    • Yasuhiro NishitaniOsamu YoshidaTsutomu IwakiIssei Kato
    • A61K38/00C07K9/00A61P43/00
    • C07K9/008A61K38/00A61K38/04
    • The present invention provides a novel glycopeptide antibiotic derivative.These derivatives are represented by the formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein RA is —X1—Ar1—X2—Y—X3—Ar2 wherein X1, X2 and X3 are single bond; heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR1— (R1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO2—, or a linkage thereof; or alkylene or alkenylene optionally substituted and optionally interrupted by one or more of said heteroatom-containing group; Y is —NR2CO—, —CONR2— (R2 is hydrogen or lower alkyl), or a group of the formula (II) wherein R3 is alkylene; Ar1 and Ar2 are a carbocycle or a heterocycle which is optionally substituted and may have an unsaturated bond; RB is —NHNRXRY or —NRZORW wherein RX is hydrogen or lower alkyl; RY is hydrogen, optionally substituted lower alkyl, C(═NH)NH2, CSNH2, COCONH2, CN, optionally substituted heterocyclic group, and optionally substituted carbamoyl; RZ is hydrogen or lower alkyl; RW is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted heterocyclic group, optionally substituted heterocyclic carbonyl or optionally substituted carbamoyl; RC is hydrogen or optionally substituted alkyl, wherein said alkyl may be interrupted by a heteroatom-containing group selected from N═, ═N—, —NR1— (R1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO2—; and R is optionally substituted alkyl.
    • 本发明提供了一种新型糖肽抗生素衍生物。 这些衍生物由式(I)表示或其药学上可接受的盐或溶剂化物,其中RA为-X1-Ar1-X2-Y-X3-Ar2,其中X1,X2和X3为单键; 选自-N-,-N-,-NR1-(R 1为氢或低级烷基), - , - - , - S - , - SO - 和-SO 2 - 或其连接基团 ; 或任选被取代并任选被一个或多个所述含杂原子基团中断的亚烷基或亚烯基; Y是-NR 2 CO-,-CONR 2 - (R 2是氢或低级烷基)或式(II)的基团,其中R 3是亚烷基; Ar1和Ar2是任选被取代并可具有不饱和键的碳环或杂环; RB是-NHNRXRY或-NRZORW,其中RX是氢或低级烷基; RY是氢,任选取代的低级烷基,C(-NH)NH 2,CSNH 2,COCONH 2,CN,任选取代的杂环基和任选取代的氨基甲酰基; RZ是氢或低级烷基; RW是氢,任选取代的低级烷基,任选取代的低级烯基,任选取代的杂环基,任选取代的杂环羰基或任选取代的氨基甲酰基; RC是氢或任选取代的烷基,其中所述烷基可以被选自N-,-N-,-NR1-(R 1是氢或低级烷基),-O - , - S - , - SO-和-SO 2 - ; R是任选取代的烷基。
    • 19. 发明申请
    • Information processing apparatus and display control method
    • 信息处理装置及显示控制方法
    • US20070242159A1
    • 2007-10-18
    • US11812397
    • 2007-06-19
    • Tsutomu Iwaki
    • Tsutomu Iwaki
    • H04N5/46H04N9/74
    • H04N5/44591G06F3/14G09G5/14G09G5/363G09G2320/0613G09G2340/0407G09G2340/125H04N21/41407H04N21/4143H04N21/42653H04N21/440263H04N21/4858
    • An information processing apparatus including: a display that is capable of displaying moving image data in a full screen mode; a first signal processing section that generates a signal for forming the moving image data to be displayed on the display; a second signal processing section that executes image quality processing for the signal generated by the first signal processing section; a determination section that determines whether or not a display mode to display the moving image data is the full screen mode based on a relationship between a screen size of the moving image data and a screen size of the display; and a control section that enables the signal subjected to the image quality processing by the second signal processing section to be output to the display when the determination section determines that the display mode to display the moving image data is the full screen mode.
    • 一种信息处理设备,包括:能够以全屏模式显示运动图像数据的显示器; 第一信号处理部,其生成用于形成要在显示器上显示的运动图像数据的信号; 第二信号处理部,对由所述第一信号处理部生成的信号进行图像质量处理; 确定部分,其基于所述运动图像数据的屏幕尺寸和所述显示器的屏幕尺寸之间的关系,确定显示所述运动图像数据的显示模式是否为全屏模式; 以及控制部,其使得当所述判定部判定为显示所述运动图像数据的显示模式为全屏模式时,能够将由所述第二信号处理部进行了图像质量处理的信号输出到所述显示。